148 related articles for article (PubMed ID: 11069443)
1. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals.
Bagheri H; Michel F; Lapeyre-Mestre M; Lagier E; Cambus JP; Valdiguié P; Montastruc JL
Br J Clin Pharmacol; 2000 Nov; 50(5):479-84. PubMed ID: 11069443
[TBL] [Abstract][Full Text] [Related]
2. Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals.
Dugué A; Bagheri H; Lapeyre-Mestre M; Tournamille JF; Sailler L; Dedieu G; Salvayre R; Thouvenot JP; Massip P; Montastruc JL
Eur J Clin Pharmacol; 2004 Jun; 60(4):285-92. PubMed ID: 15114428
[TBL] [Abstract][Full Text] [Related]
3. Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals.
Tavassoli N; Duchayne E; Sadaba B; Desboeuf K; Sommet A; Lapeyre-Mestre M; Muoz MJ; Sie P; Honorato J; Montastruc JL; Bagheri H
Eur J Clin Pharmacol; 2007 Mar; 63(3):221-8. PubMed ID: 17225990
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment.
Cano-Paniagua A; Amariles P; Angulo N; Restrepo-Garay M
Ann Hepatol; 2019; 18(3):501-507. PubMed ID: 31053545
[TBL] [Abstract][Full Text] [Related]
5. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
[TBL] [Abstract][Full Text] [Related]
6. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
[TBL] [Abstract][Full Text] [Related]
7. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
[TBL] [Abstract][Full Text] [Related]
8. Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital.
Gaskill CL; Miller LM; Mattoon JS; Hoffmann WE; Burton SA; Gelens HC; Ihle SL; Miller JB; Shaw DH; Cribb AE
Vet Pathol; 2005 Mar; 42(2):147-60. PubMed ID: 15753468
[TBL] [Abstract][Full Text] [Related]
9. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.
Egger T; Dormann H; Ahne G; Runge U; Neubert A; Criegee-Rieck M; Gassmann KG; Brune K
Drugs Aging; 2003; 20(10):769-76. PubMed ID: 12875612
[TBL] [Abstract][Full Text] [Related]
10. Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance.
Francis GS; Grumser Y; Alteri E; Micaleff A; O'Brien F; Alsop J; Stam Moraga M; Kaplowitz N
Drug Saf; 2003; 26(11):815-27. PubMed ID: 12908850
[TBL] [Abstract][Full Text] [Related]
11. Anti-infectives-induced adverse drug reactions in hospitalized patients.
Gholami K; Parsa S; Shalviri G; Sharifzadeh M; Assasi N
Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced liver injury in the Australian setting.
Sistanizad M; Peterson GM
J Clin Pharm Ther; 2013 Apr; 38(2):115-20. PubMed ID: 23350857
[TBL] [Abstract][Full Text] [Related]
13. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
14. Reporting adverse drug reactions on a geriatric ward: a pilot project.
Somers A; Petrovic M; Robays H; Bogaert M
Eur J Clin Pharmacol; 2003 Feb; 58(10):707-14. PubMed ID: 12610749
[TBL] [Abstract][Full Text] [Related]
15. Propafenone-induced liver injury.
Spinler SA; Elder CA; Kindwall KE
Ann Pharmacother; 1992; 26(7-8):926-8. PubMed ID: 1354511
[TBL] [Abstract][Full Text] [Related]
16. Hepatic adverse drug reactions: a case/non-case study in Italy.
Motola D; Vargiu A; Leone R; Cocci A; Salvo F; Ros B; Meneghelli I; Venegoni M; Cutroneo PM; Vaccheri A; Velo G; Montanaro N
Eur J Clin Pharmacol; 2007 Jan; 63(1):73-9. PubMed ID: 17119945
[TBL] [Abstract][Full Text] [Related]
17. A strategy to improve the detection of drug-induced hepatotoxicity.
Ruiz Montero A; Durán Quintana JA; Jiménez Sáenz M; Abadín Delgado JA
Rev Esp Enferm Dig; 2005 Mar; 97(3):155-60. PubMed ID: 15839810
[TBL] [Abstract][Full Text] [Related]
18. Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program.
Friedrich ME; Akimova E; Huf W; Konstantinidis A; Papageorgiou K; Winkler D; Toto S; Greil W; Grohmann R; Kasper S
Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26721950
[TBL] [Abstract][Full Text] [Related]
19. Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population.
Makar GA; Weiner MG; Kimmel SE; Bennett D; Burke A; Yang YX; Han X; Sellers K; Nessel L; Lewis JD
Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):43-51. PubMed ID: 17960855
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions in patients in an Iranian department of internal medicine.
Pourseyed S; Fattahi F; Pourpak Z; Gholami K; Shariatpanahi SS; Moin A; Kazemnejad A; Moin M
Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):104-10. PubMed ID: 19101919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
